Center Overview

Paragon Research Center is a physician owned state of the art research center designed to conduct phase II, III, and IV studies in primary care  for pharmaceutical and CRO sponsors. It is a dedicated research center with 3 fulltime certified coordinators, 3 fulltime research assistants, 1 part time certified dietician, 1 fulltime administrative assistant and a fulltime administrator. The intimate staff size allows for personalized attention to our customers, our sponsors/CRO's and our research volunteers.

The PI provides daily hands on oversight of all research activities. The PI reviews all study protocols with the coordinators prior to participation and they, together, decide on feasibility to perform the study and if the study goals are achievable.  If participation is agreed upon, two coordinators are assigned to the study, one as the lead, the other as back-up. One of these coordinators completes the regulatory documents with a turn around time of 3 to 5 business days. The administrator handles the budget and the contract (with oversight by the Medical Director) and a turn around time of 3 to 5 business days. The PI and the lead coordinator attend the investigators meeting and then inform the appropriate personnel about the protocol, designated duties, all known safety data and side affects of the study drug prior to study start. The principle investigator oversees the selection of trial subjects, the informed consent process, monitors participants safety during the study, signs all lab and EKG's, x-rays, reviews all adverse events and study documents and performs all required protocol related procedures. One of the important strengths of Paragon Research Center is the active involvement of the Principal Investigator. 

Our Goals

• Perform, maintain and excel in providing high quality, reproducible research results and hold ourselves and our staff to the highest standards in medical and research expertise.
• Play an integral role in contributing to our future's new and innovative pharmaceuticals therapies being approved by the FDA and made available to the intended recipients.
• Take complete responsibility for the services we provide and or delegate as we conduct clinical trials and keep study participant safety and compliance with regulatory requirements a top priority.
• Understand and tend to the needs of our customers, the pharmaceutical companies and study participants, and maintain vigilance regarding the importance of personalized one on one attention with both of them.
• Create a stable enjoyable working environment for our staff that promotes camaraderie, team play and a desire to help one another as well as personal achievement, growth, and fulfillment.